Furthermore, administration of the FMS-like tyrosine kinase 3 ligand (FLT3L) was demonstrated to increase cDC proliferation and ultimately tumour infiltration in a mouse model of melanoma [36]. This evidence concerns the gene FLT3LG and neoplasm.